Log in

NEWS

<< First  < Prev   1   2   3   Next >  Last >> 
  • 10 Sep 2020 9:32 AM | Anonymous member (Administrator)

    The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, investigators from the CBTCT will review major topics in stem cell transplantation and cell therapy, highlighting how the activities of the CBTCT are addressing current challenges in stem cell transplantation. The fourth webinar of this series addresses developments in the field of cellular therapy in the management of two common post-allogeneic bone marrow transplant complications. Professor David Gottlieb will highlight the role of cell therapies in the treatment of opportunistic infections in the post-transplant period, while Dr Siok Tey will review novel cellular therapies for the treatment of graft vs host disease

    Speakers:

    Professor David Gottlieb – Westmead Hospital / University of Sydney

    Dr Siok Tey - Royal Brisbane and Womens Hospital / QIMR Berghofer Medical Research Institute

    When: Thursday 3 September 2020, 8am AEST

    Link to webinar

    Link to CBTCT website for all webinar recordings

    For more information

  • 7 Sep 2020 3:27 PM | Anonymous member (Administrator)

    A reminder of changes for the 2020 CPD year only.

    The RACP recognises that the innovation and learning it is currently seeing from our medical profession is perhaps the ultimate CPD. The RACP will not take action if you cannot meet CPD requirements in 2020. You are not required to record CPD activities that you have completed in 2020, and the College will not be monitoring or auditing your 2020 CPD record.

    The Medical Board of Australia has stated that AHPRA will not take action if you cannot meet the CPD registration standard when you renew your medical registration in 2020.

    The Medical Council of New Zealand has waived recertification requirements for 2020.

    For more information visit the MyCPD interactive handbook  or contact the MyCPD Unit in Australia on 1300 697 227 or at MyCPD@racp.edu.au and in New Zealand on +64 4 460 8122 or at MyCPD@racp.org.nz

  • 28 Aug 2020 10:22 AM | Anonymous member (Administrator)

    Call for HSANZ Members to submit original research abstracts for the Baikie Symposium. HSANZ day of the ALLG Scientific Meeting, Tuesday 13 October, 2020. 

    • Unfortunately, Blood2020 has been postponed in view of the travel restrictions associated with the COVID-19 pandemic. 

      To ensure that we can continue offer our fellow Haematologists and trainees the best opportunity to access the latest local and international research, HSANZ are delighted to be partnering with ALLG to offer a one-day session on 13 October 2020. 

      In particular, we will offer the 2020 Baikie symposium and award for the best research by a HSANZ  Full, Trainee or Associate member. HSANZ encourages  members to submit an abstract for an oral presentation. The Committee seeks original papers that address scientific questions, demonstrate new research / developments or contain original scientific results related to haematology. 

      All abstract submissions must be sent in a Word document to admin@hsanz.org.au.  The submission deadline is 11.59pm Sunday 20 September 2020 AEST. Acceptance of Abstracts will be confirmed by email in late September. Unfortunately, due to the tight deadline, we cannot consider any extensions of the deadline this year.

      The Baikie Award will be made for the best Abstract presented by a trainee. Criteria

      Eligibility:

    • Must be a financial Member of HSANZ
    • All author(s) must approve of submitting this work for presentation, and the submitting author needs to be available to present the abstract if selected for the program. Authors need to notify the HSANZ Secretariat if they are unable to present or if the presenting author is changed. The presentation will be using a virtual platform.
    • Abstract titles should be short, descriptive and not contain abbreviations. Abstracts should be thoroughly checked for spelling and grammar before they are submitted online.
    • Abstracts can contain standard abbreviations (spelled out on first use), tables, pictures and diagrams, but should not include symbols (e.g. arrows, Greek symbols) nor languages other than English. 
    • The abstracts should be original work, not previously published
    • Only ONE abstract is to be nominated by each applicant
    • Previous winners of the award are ineligible 

    Abstract Submission Guidelines:

    -       The abstract must address scientific questions, detail clinical observations, or contain primary scientific data.

    -       Your name, degree, institution, address, phone number, and e-mail address must be provided. 

    -       The corresponding author should be the first author (presenter) of the abstract, unless otherwise noted during submission.

  • 26 Aug 2020 5:32 PM | Anonymous member (Administrator)

    The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, investigators from the CBTCT will review major topics in stem cell transplantation and cell therapy, highlighting how the activities of the CBTCT are addressing current challenges in stem cell transplantation. In the third seminar of this series, Professor James Ferrara will outline research highlighting biomarkers in graft vs host disease and the role of the MAGIC Consortium, while Dr Siok Tey will review novel cellular therapies for the treatment of graft vs host disease.

    Speakers:

    Professor James Ferrara - Tisch Cancer Institute, Icahn School of Medicine at Mt Sinai

    Dr Siok Tey - Royal Brisbane and Womens Hospital / QIMR Berghofer Medical Research Institute

    When: Thursday 3 September 2020, 8am AEST

    Link to webinar: https://uni-sydney.zoom.us/j/92998014030

    Link to CBTCT website for all webinar recordings:

    https://bloodcelltherapy.org.au/

    For the PDF flyer, click here

  • 18 Aug 2020 11:20 AM | Anonymous member (Administrator)

    The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, investigators from the CBTCT will review major topics in stem cell transplantation and cell therapy, highlighting how the activities of the CBTCT are addressing current challenges in stem cell transplantation. Following on in this series, Professor David Curtis from the Alfred Hospital in Melbourne will review the role of post-transplant cyclophosphamide for the prevention of graft versus host disease following allogeneic blood transplant. Mr Mingdi Xie, who is the current MAGIC Australia Project coordinator for the CBTCT, will then present an introduction to the MAGIC consortium, including its functions and importance in allogeneic blood transplant research

    Speakers:

    Professor David Curtis – The Alfred Hospital and Monash University

    Mr Mingdi Xie – The Royal Melbourne Hospital and Peter MacCallum Cancer Centre

    When: Thursday 20 August 2020, 8am AEST

    For more information and the link to the webinar click here

    Website: bloodcelltherapy.org.au 

  • 18 Aug 2020 10:07 AM | Anonymous member (Administrator)

    Introduction to MSAC Webinar – Thu 27 August 2020

    The Department of Health will be hosting an Introduction to Medical Services Advisory Committee (MSAC) Webinar on

    Thursday 27 August 2020
    3-4pm AEST

    This webinar aims to provide basic information on the role of MSAC.

    Please register here: Introduction to MSAC Webinar Registration

    MSAC website
    HTA website
    Email

  • 10 Aug 2020 5:23 PM | Anonymous member (Administrator)

    You are invited to the Myeloma and Related Diseases Registry webinar

    - this is a free double event as it forms part of the National Myeloma Workshop (NMW) this year. 

    Please join MRDR for an update on registry progress, projects and Q&A.
    Date: Saturday, 5 September
    Time: 4:00 – 5:00 pm AEST – NMW sessions stream through to the MRDR webinar
    You need to register for this dual free event: MRDR webinar and NMW, at  https://www.trybooking.com/BKMLT 

    For full details of the NMW go here

  • 6 Aug 2020 3:02 PM | Anonymous member (Administrator)

    MPN Alliance Australia established a website in 2018 for MPN patients and their families. 

    They work in partnership with the Leukaemia Foundation and aim to provide high quality, evidence-based MPN information.

    They have invited us to raise awareness amongst haematologists of their website and patient treatment information available for download in PDF in English and Arabic.
    Please see attached letter.  

  • 28 Jul 2020 11:17 AM | Anonymous member (Administrator)

    The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, investigators from the CBTCT will review major topics in stem cell transplantation and cell therapy, highlighting how the activities of the CBTCT are addressing current challenges in stem cell transplantation. In this first webinar of the series, Professor Geoff Hill from the Fred Hutchinson Cancer Research Centre in Seattle will review the pathogenesis of graft versus host disease and discuss approaches to its prevention and treatment. Professor David Gottlieb will review the evidence for use of anti-T cell antibodies for prophylaxis of acute and chronic graft versus host disease in allogeneic stem cell transplant 

    Speakers:

    Professor Geoff Hill - Fred Hutchinson Cancer Research Centre

    Professor David Gottlieb - Westmead Hospital and University of Sydney

    When: 6 August 2020 8am AEST

    To register: download flyer 

    For more information: bloodcelltherapy.org.au


  • 23 Jul 2020 6:48 PM | Anonymous member (Administrator)

    As you may be aware the RACP recently released the results of their survey of the use of new MBS  telehealth items by members. 

    They are currently developing a short paper on policy options to optimise the use of the new telehealth items beyond the COVID-19 pandemic which has been refined following consultation with members of the College Health Reform Reference Group (here). This paper is still a draft and would be finalised following extensive consultation with all specialties. Can you please provide any feedback on this paper to RACP by COB 4 August

    If you would prefer to send your feedback to Valerie in the office, by COB 3 August, she will collate and send this to RACP.

<< First  < Prev   1   2   3   Next >  Last >> 

CONTACT

Haematology Society of Australia and New Zealand (HSANZ)
145 Macquarie Street, Sydney NSW 2000
Tel: 02 8097 8114


FOLLOW US

Copyright © 2020 Haematology Society of Australia & New Zealand (HSANZ). All Rights Reserved.

Powered by Wild Apricot Membership Software